Document Classification

Section Type: RESULTS

Text: Median percent reductions from baseline in POS frequency/week were 21. 7 % (placebo), 29. 9 % (BRV5 ; p = 0. 086), 42. 6 % (BRV20 ; p = 0. 014), and 53. 1 % (BRV50 ; p < 0. 001) ; > or = 50 % responder rates were 16. 7 % (placebo), 32. 0 % (BRV5 ; p = 0. 047), 44. 2 % (BRV20 ; p = 0. 002), and 55. 8 % (BRV50 ; p < 0. 001) ; seizure freedom rates (POS) during the 7-week treatment period were 1. 9 % (placebo), 8. 0 % (BRV5 ; p = 0. 193), 7. 7 % (BRV20 ; p = 0. 193), and 7. 7 % (BRV50 ; p = 0. 201).